Another alliance of health care and AI signals why pharma stocks should be back in favor
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.
Real-time market intelligence across asset classes
Chart, AI analysis, key levels, technical analysis, sentiment, and market news are grouped so the next action is always visible.
Over the last 30 days, AI sentiment for MA skewed bullish (3 of 7 scored calls).
| Insider | Role | Date | Type | Value |
|---|---|---|---|---|
| Ling Hai | President, AP, … | Feb 23 '26 | Option Exercise | 404189.0 |
| Ling Hai | President, AP, … | Feb 24 '26 | Option Exercise | 404098.0 |
| Ling Hai | President, AP, … | Feb 23 '26 | Sale | 2255045.0 |
| Ling Hai | President, AP, … | Feb 24 '26 | Sale | 2223269.0 |
| HAI LING | Officer | Feb 24 '26 | Proposed Sale | 2224695.0 |
| HAI LING | Officer | Feb 23 '26 | Proposed Sale | 2361475.0 |
| SACHIN J. MEHRA | Chief Financial … | Sep 02 '25 | Option Exercise | 5319348.0 |
| SACHIN J. MEHRA | Chief Financial … | Sep 02 '25 | Sale | 10202458.0 |
| SACHIN MEHRA | Officer | Sep 02 '25 | Proposed Sale | 10276491.0 |
| Ling Hai | President, AP, … | Aug 22 '25 | Option Exercise | 404098.0 |
Source: FinViz — Data may be delayed
AI-curated news influencing MA price, sentiment, and trend
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.
Cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás Maduro.
The broader tech sell-off weighed on the recent IPO.
Multi-Provider AI Analysis